Dirk Vetter | CEO
Adherent Health
Dr. Dirk Vetter, co-founder and CEO of Adherent Health. Co-founder and CEO of Complex Biosystems, a start-up that created TransCon technology (acquired by Ascendis Pharma, NASDAQ:ASND and matured into three approved TransCon drugs). Co-founder and CEO of Graffinity Pharmaceuticals (now Santhera, SIX:SANN), co-inventor of Graffinitys label-free fragment screening platform (acquired by Novalix).
Appearances:
last published: 21/Sep/26 11:05 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events